Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Shire
Shire
Shire's new Baxalta hemophilia meds drop the ball in first combined quarter
Fierce Pharma
Wed, 11/2/16 - 09:56 am
Shire
Baxalta
hemophilia
earnings
Shire confident in hemophilia despite looming pricing challenge
BioPharma Dive
Tue, 11/1/16 - 04:55 pm
Shire
hemophilia
drug pricing
PBMs
Shire bids CTI and its troubled myelofibrosis drug adieu, buying its way out of a deal
Endpoints
Tue, 10/25/16 - 09:54 am
Shire
myelofibrosis
CTI BioPharma
Baxalta
M&A
pacritinib
AbbVie Is Under Duress With Fierce Competition
Seeking Alpha
Thu, 10/20/16 - 09:20 am
AbbVie
Humira
biosimilars
Amgen
Baxalta
Shire
Shire wants consumers and their eyes to be 'Friends'
BioPharma Dive
Thu, 10/13/16 - 10:40 am
Shire
celebrity endorsements
dry eye disease
Xiidra
Shire punts late-stage biosimilars of Humira and Enbrel back to Momenta, Coherus
Endpoints
Wed, 09/28/16 - 10:18 am
Shire
biosimilars
Humira
Enbrel
Momenta
Shire wants out of that $172M Baxalta deal with CTI Bio
Endpoints
Mon, 09/19/16 - 06:03 pm
Shire
Baxalta
CTI BioPharma
M&A
Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market
Medical Marketing and Media
Fri, 08/26/16 - 10:02 am
Shire
dry eye disease
Xiidra
celebrity endorsements
GSK, Merck shares win as 2016 brings big moves. Losers? You know who
Fierce Pharma
Tue, 08/23/16 - 10:00 am
GSK
Merck
Valeant Pharmaceuticals
Endo International
Sagent Pharmaceuticals
Alkermes
Shire
Perrigo
Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Bidness, ETC
Fri, 08/19/16 - 11:50 am
Shire
Raptor Pharmaceuticals
M&A
Retrophin
Rare Diseases
In the Spirit of the Olympics: On and Off the Pharma Podium
PharmExec
Sat, 08/13/16 - 06:44 pm
Shire
Xiidra
Bayer
JNJ
beloranib
Zafgen
GSK
Valeant Pharmaceuticals
Shire launches new treatment for hereditary bleeding disorder
BioPharma Dive
Thu, 08/11/16 - 09:30 am
Shire
drug launches
Vonvendi
von Willebrand disease
Elliott Associates sues AbbVie over failed bid for Shire
Yahoo/Reuters
Sat, 08/6/16 - 01:11 pm
AbbVie
Shire
M&A
Shire cans Baxalta hemophilia B gene therapy, thinning field for uniQure, Spark
Fierce Biotech
Wed, 08/3/16 - 09:39 am
Shire
Baxalta
hemophilia B
gene therapy
BAX 335
Spark Therapeutics
uniQure
Shire upgrades Baxalta cost savings after Q2 earnings beat
Yahoo/Reuters
Tue, 08/2/16 - 09:03 am
Shire
Baxalta
earnings
The Shire Vs. Allergan War Has Begun
Seeking Alpha
Mon, 08/1/16 - 09:39 am
Shire
Allergan
dry eye disease
Xiidra
Restasis
Shire targets Allergan's dry-eye market share by pricing Xiidra at $5K per year--right on par with Restasis
Fierce Pharma
Tue, 07/26/16 - 11:25 am
dry eye disease
Shire
Allergan
Xiidra
Restasis
Shire bags a quick thumbs up for its newly won cancer drug pipeline
Endpoints
Mon, 07/25/16 - 11:15 am
Shire
Baxalta
M&A
Onivyde
Six Major Biotech Acquisitions You Could See in 2016 (Part 2)
Forbes
Mon, 07/25/16 - 09:51 am
biotech
M&A
Pfizer
Teva Pharmaceutical
Allergan
Shire
Portola Pharmaceuticals
Sanofi
Medivation
Regeneron
Biogen
Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta
TheStreet.com
Thu, 07/14/16 - 07:21 pm
Shire
ADHD
Baxalta
Brexit
M&A
Vyvanse
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »